How Biden's New Opioid Initiative Could Create More Drug Addicts
White House set to make naloxone available over the counter. Experts say it won't help the opioid crisis.
A key component of President Joe Biden’s effort to combat the opioid crisis could backfire and lead to both an increase in overdoses and demand for narcotics, experts warn.
The White House is making naloxone, a drug used to reverse opioid overdoses, available over the counter. Public health experts say the policy is not only a tacit admission that deadly opioids such as fentanyl are here to stay but could end up creating more addicts or causing more overdoses.
"This move doesn’t address our addiction crisis in the slightest," said Dr. Keith Humphreys, a Stanford University professor who has helped craft drug policy in multiple White Houses and in the United Kingdom. "You would never say 'Okay, I’m rolling out a new plan for cancer for the country, we’re going to open a lot more hospice facilities.'"
The policy change was revealed on Tuesday as part of an initiative to crack down on illicit fentanyl supply chains. It comes amid bipartisan criticism that the Biden administration has largely overlooked the drug crisis that has claimed hundreds of thousands of American lives over the last decade.
The focus on easing the availability of naloxone continues the White House’s broader focus on so-called harm reduction, a public health theory that posits governments should work to minimize the potential hazards surrounding drug use, rather than work to end it. The Biden administration’s harm reduction approach, which most notably included their funding for safe smoking kits that contain crack pipes, has garnered widespread criticism.
At least 106,699 Americans died from a drug overdose in 2021, the year with the most recently available data. Most of those deaths were due to fentanyl or other synthetic opioids. The rate of overdose deaths in the United States has more than tripled since 2001.
There is no disputing the fact that naloxone saves the lives of someone suffering from an opioid-related overdose. If immediately supplied—typically in the form of a nasal spray—to someone who ingested a fatal amount of fentanyl, for example, naloxone essentially blocks the effect of that drug.
But naloxone does not treat addiction and may actually encourage more drug use. At least one study concluded in 2018 that proliferation of the drug increased opioid-related deaths by 14 percent in the midwest. The authors also found "that broadening naloxone access increased the use of fentanyl."
"Being addicted to drugs sucks," said Humphreys. "That’s not reduced by things such as naloxone."
https://freebeacon.com/biden-administration/how-bidens-new-opioid-initiative-could-create-more-drug-addicts/